Recent developments and controversies in therapeutic hypothermia after cardiopulmonary resuscitation - 13/01/23
Abstract |
Therapeutic hypothermia was recommended as the only neuroprotective treatment in comatose patients after return of spontaneous circulation (ROSC). With new evidence suggesting a similar neuroprotective effect of 36 °C and 33 °C, the term “therapeutic hypothermia” was substituted by “targeted temperature management” in 2011, which in turn was replaced by the term “temperature control” in 2022 because of new evidence of the similar effects of target normothermia and 33 °C. However, there is no clear consensus on the efficacy of therapeutic hypothermia. In this article, we provide an overview of the recent evidence from basic and clinical research related to therapeutic hypothermia and re-evaluate its application as a post-ROSC neuroprotective intervention in clinical settings.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiopulmonary resuscitation, Return of spontaneous circulation, Therapeutic hypothermia, Targeted temperature management, Temperature control
Plan
Vol 64
P. 1-7 - février 2023 Retour au numéro
Article précédent
- Learning from the COVID-19 pandemic: IMCU as a more efficient model of pediatric critical care organization
- Giacomo Brisca, Giacomo Tardini, Daniela Pirlo, Marta Romanengo, Isabella Buffoni, Marisa Mallamaci, Valentina Carrato, Barbara Lionetti, Marta Molteni, Elio Castagnola, Andrea Moscatelli
- Aerosol containment device design considerations and performance evaluation metrics
- Rachael M. Jones, Niles Andrus, Thomas Dominguez, Jeremy Biggs, Brian Hansen, Frank A. Drews
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?